The weekly litigation news digest is live. Subscribe now
Nicotinamide Mononucleotide Derivatives And Use Thereof In The Treatment And Prevention Of A Red Blood Cell Disorder - EP4196127
The patent EP4196127 was granted to Nuvamid on Jan 31, 2024. The application was originally filed on Dec 17, 2021 under application number EP21839533A. The patent is currently recorded with a legal status of "Granted And Under Opposition".
EP4196127
- Application Number
- EP21839533A
- Filing Date
- Dec 17, 2021
- Status
- Granted And Under Opposition
- Dec 29, 2023
- Publication Date
- Jan 31, 2024
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (6) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents